Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 28;9:839571. doi: 10.3389/fcvm.2022.839571

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Bi, Yi, Wu, Hu, Zhang, Lu, Liu, Zhang, Yang, Cui, Xu, Song, Guo, Li and Zheng.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Use of lipid-lowering medications and distribution of LDL-C levels before and after the lipid-lowering therapy simulation, by 10-year ASCVD risk stratifications. UNK, unknown name or not guideline-recommended medications; HMIS, maximized uptake of moderate-intensity statins, including: atorvastatin 20 mg, simvastatin 40 mg, rosuvastatin 10 mg, pravastatin 40 mg, pitavastatin 4 mg, lovastatin 40 mg, or fluvastatin 80 mg; LMIS, statins with doses less than HMIS; EZE, ezetimibe; EVO, evolocumab 140 mg, biweekly.